595 related articles for article (PubMed ID: 20035910)
1. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
Joffe H; Petrillo L; Viguera A; Koukopoulos A; Silver-Heilman K; Farrell A; Yu G; Silver M; Cohen LS
Am J Obstet Gynecol; 2010 Feb; 202(2):171.e1-171.e11. PubMed ID: 20035910
[TBL] [Abstract][Full Text] [Related]
2. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
Soares CN; Joffe H; Rubens R; Caron J; Roth T; Cohen L
Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
[TBL] [Abstract][Full Text] [Related]
3. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.
Pollack MH; Hoge EA; Worthington JJ; Moshier SJ; Wechsler RS; Brandes M; Simon NM
J Clin Psychiatry; 2011 Jul; 72(7):892-7. PubMed ID: 21367352
[TBL] [Abstract][Full Text] [Related]
4. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
5. Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone.
Boyle J; Trick L; Johnsen S; Roach J; Rubens R
Hum Psychopharmacol; 2008 Jul; 23(5):385-97. PubMed ID: 18350566
[TBL] [Abstract][Full Text] [Related]
6. Severe hot flashes are associated with chronic insomnia.
Ohayon MM
Arch Intern Med; 2006 Jun; 166(12):1262-8. PubMed ID: 16801508
[TBL] [Abstract][Full Text] [Related]
7. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
8. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
9. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
Roth T; Walsh JK; Krystal A; Wessel T; Roehrs TA
Sleep Med; 2005 Nov; 6(6):487-95. PubMed ID: 16230048
[TBL] [Abstract][Full Text] [Related]
11. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
12. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes.
Ensrud KE; Stone KL; Blackwell TL; Sawaya GF; Tagliaferri M; Diem SJ; Grady D
Menopause; 2009; 16(2):286-92. PubMed ID: 19002015
[TBL] [Abstract][Full Text] [Related]
13. The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
Tek C; Palmese LB; Krystal AD; Srihari VH; DeGeorge PC; Reutenauer EL; Guloksuz S
Schizophr Res; 2014 Dec; 160(1-3):180-5. PubMed ID: 25454802
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
Al-Akoum M; Maunsell E; Verreault R; Provencher L; Otis H; Dodin S
Menopause; 2009; 16(2):307-14. PubMed ID: 19194342
[TBL] [Abstract][Full Text] [Related]
15. Hot flashes are associated with psychological symptoms of anxiety and depression in peri- and post- but not premenopausal women.
Juang KD; Wang SJ; Lu SR; Lee SJ; Fuh JL
Maturitas; 2005 Oct; 52(2):119-26. PubMed ID: 16186074
[TBL] [Abstract][Full Text] [Related]
16. A multinational study of sleep disorders during female mid-life.
Blümel JE; Cano A; Mezones-Holguín E; Barón G; Bencosme A; Benítez Z; Bravo LM; Calle A; Flores D; Espinoza MT; Gómez G; Hernández-Bueno JA; Laribezcoa F; Martino M; Lima S; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Sánchez H; Tserotas K; Vallejo MS; Witis S; Zúñiga MC; Chedraui P
Maturitas; 2012 Aug; 72(4):359-66. PubMed ID: 22717489
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
[TBL] [Abstract][Full Text] [Related]
18. Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.
Seritan AL; Iosif AM; Park JH; DeatherageHand D; Sweet RL; Gold EB
Menopause; 2010 Mar; 17(2):410-5. PubMed ID: 20216277
[TBL] [Abstract][Full Text] [Related]
19. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Women's Health Initiative Insomnia Rating Scale in a multicenter controlled clinical trial.
Levine DW; Dailey ME; Rockhill B; Tipping D; Naughton MJ; Shumaker SA
Psychosom Med; 2005; 67(1):98-104. PubMed ID: 15673630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]